ELV — Elevance Health, Inc.

NYSE · Financials · Insurance · CIK 1156039 ·
Last close
$395.18
Market Cap
$85.82B
52W High
$426.98
52W Low
$281.32
ADV30
1,743,397
Next earnings
2026-07-16
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 50,181,000,000 1,764,000,000 125,827,000,000 9,657,000,000 81,785,000,000
Dec 2025 49,747,000,000 547,000,000 121,494,000,000 9,491,000,000 77,468,000,000
Sep 2025 50,711,000,000 1,189,000,000 122,749,000,000 8,713,000,000 78,667,000,000
Jun 2025 49,776,000,000 1,743,000,000 121,938,000,000 8,560,000,000 78,087,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$7,605,000,000
Investing CF
$-3,089,000,000
Financing CF
$-2,344,000,000
CapEx
$-1,155,000,000
Dividends Paid
$-1,519,000,000
Buybacks
$-2,849,000,000
EPS Diluted TTM
$23.51
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$35,796,000,000
Inventory
Receivables
$22,790,000,000
ST Investments
$25,905,000,000
EBIT TTM
$7,632,000,000
Pretax Income TTM
$6,217,000,000
Interest Exp TTM
$1,415,000,000
Analysts
21

Yahoo Snapshot (yfinance, live)

Total Revenue
$200,416,002,048
EBITDA
$8,541,000,192
Free Cash Flow
$4,298,625,024
Enterprise Value
$80,727,228,416
Total Cash
$37,072,998,400
Total Debt
$31,842,000,896
Shares Out
217,162,380
Trailing EPS
$23.59
Book Value
$201.97
ROE
12.1%
ROA
4.0%
Div Yield
1.74%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 199,125,000,000 5,662,000,000 121,494,000,000 77,468,000,000 4,290,000,000
Dec 2024 176,810,000,000 5,980,000,000 116,889,000,000 75,463,000,000 5,808,000,000
Dec 2023 171,340,000,000 5,987,000,000 108,928,000,000 69,523,000,000 8,061,000,000
Dec 2022 156,595,000,000 5,894,000,000 102,755,000,000 66,425,000,000 8,399,000,000

TTM Snapshot

Revenues TTM
$166,526,000,000
NetIncome TTM
$5,545,000,000
OpCashFlow TTM
$0
Assets (Latest)
$116,889,000,000
Forward EPS
$29.25

Max Pain — expiry 2026-07-17

max pain strike: $390.00 · spot: $390.02 · call oi: 3,148 · put oi: 2,593
Expected Move to 2026-07-17: ±$26.75 (6.86%) — implied range $363.27$416.77 · ATM straddle on $390.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
MRSH MARSH & MCLENNAN COMPANIES, INC. $81.44B $169.03
CI Cigna Group $74.81B $282.79
AON Aon plc $70.20B $328.69
TRV TRAVELERS COMPANIES, INC. $69.61B $327.37
MFC MANULIFE FINANCIAL CORP $67.11B $40.29

News headlines (Yahoo Finance, 1h cache)

2 Reasons to Like ELV (and 1 Not So Much)
2026-06-29 15:46 · Yahoo
How CenterWell Is Driving Humana's Growth Beyond Insurance
2026-06-29 14:44 · Yahoo
Elevance Health (ELV) Fell Amid Healthcare Sector Downturn
2026-06-29 13:42 · Yahoo
Can Carelon Drive Elevance Health's Future Earnings Growth?
2026-06-26 15:45 · Yahoo
3 Large-Cap Stocks with Exciting Potential
2026-06-26 11:20 · Yahoo
Elevance Health's Q2 2026 Earnings: What to Expect
2026-06-26 09:52 · Yahoo
How Investors Are Reacting To Elevance Health (ELV) Pairing CNSide Deal With Its Health OS Platform
2026-06-26 01:08 · Yahoo
Elevance Health (ELV) Launches Health OS To Make Care More Connected
2026-06-25 14:06 · Yahoo
New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
2026-06-25 13:00 · Yahoo
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
2026-06-25 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.